Vasoactive intestinal peptide protects against beta-amyloid-induced neurodegeneration by inhibiting microglia activation at multiple levels (Q81167475)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18442091%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

title

Vasoactive intestinal peptide protects against beta-amyloid-induced neurodegeneration by inhibiting microglia activation at multiple levels (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18442091%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

1 reference

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18442091%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18442091%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Nieves Varela

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18442091%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

publication date

1 August 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18442091%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18442091%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18442091%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18442091%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

page(s)

1091-1103

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18442091%20AND%20SRC:MED&resulttype=core&format=json

Somatostatin and vasoactive intestinal polypeptide in postmortem brains from patients with Alzheimer-type dementia

6 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20681

7 January 2021

The NF-kappa B and I kappa B proteins: new discoveries and insights

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20681

7 January 2021

Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20681

7 January 2021

Neuroprotection: a comparative view of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20681

7 January 2021

Inflammatory mechanisms in Alzheimer's disease: inhibition of beta-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARgamma agonists.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20681

7 January 2021

Guanosine inhibits CD40 receptor expression and function induced by cytokines and beta amyloid in mouse microglia cells

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20681

7 January 2021

Neuroprotective and neurorestorative strategies for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20681

7 January 2021

Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit CBP-NF-kappaB interaction in activated microglia.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20681

7 January 2021

Inhibition of interferon (IFN) gamma-induced Jak-STAT1 activation in microglia by vasoactive intestinal peptide: inhibitory effect on CD40, IFN-induced protein-10, and inducible nitric-oxide synthase expression

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20681

7 January 2021

Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit nuclear factor-kappa B-dependent gene activation at multiple levels in the human monocytic cell line THP-1.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20681

7 January 2021

Vasoactive intestinal peptide prevents activated microglia-induced neurodegeneration under inflammatory conditions: potential therapeutic role in brain trauma.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20681

7 January 2021

Neuroprotective effect of vasoactive intestinal peptide (VIP) in a mouse model of Parkinson's disease by blocking microglial activation

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20681

7 January 2021

Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit chemokine production in activated microglia

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20681

7 January 2021

Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit the production of inflammatory mediators by activated microglia

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20681

7 January 2021

The significance of vasoactive intestinal peptide in immunomodulation

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20681

7 January 2021

Independent human MAP-kinase signal transduction pathways defined by MEK and MKK isoforms

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20681

7 January 2021

Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20681

7 January 2021

Vasoactive intestinal polypeptide (VIP): distribution in normal human brain and in Huntington's disease

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20681

7 January 2021

Broad-spectrum effects of 4-aminopyridine to modulate amyloid beta1-42-induced cell signaling and functional responses in human microglia.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20681

7 January 2021

Beta-amyloid-induced inflammation and cholinergic hypofunction in the rat brain in vivo: involvement of the p38MAPK pathway.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20681

7 January 2021

Learning impairment following intracerebral administration of the HIV envelope protein gp120 or a VIP antagonist

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20681

7 January 2021

Regulation of immune tolerance by anti-inflammatory neuropeptides

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20681

7 January 2021

Anti-inflammatory neuropeptide receptors: new therapeutic targets for immune disorders?

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20681

7 January 2021

Microglia as mediators of inflammatory and degenerative diseases

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20681

7 January 2021

In vitro properties of a high affinity selective antagonist of the VIP1 receptor

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20681

7 January 2021

Development of high affinity selective VIP1 receptor agonists

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20681

7 January 2021

Neuroprotective strategy for Alzheimer disease: intranasal administration of a fatty neuropeptide

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20681

7 January 2021

Learning and sexual deficiencies in transgenic mice carrying a chimeric vasoactive intestinal peptide gene

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20681

7 January 2021

Vasoactive intestinal peptide gene expression from embryos to aging rats

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20681

7 January 2021

Vasoactive intestinal peptide upregulates MUC2 intestinal mucin via CREB/ATF1.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20681

7 January 2021

Microglia and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20681

7 January 2021

Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20681

7 January 2021

Quantitative determination of glutamate mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux assay

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20681

7 January 2021

Role of p38 and p44/42 mitogen-activated protein kinases in microglia

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20681

7 January 2021

Nuclear protein CBP is a coactivator for the transcription factor CREB

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20681

7 January 2021

Nonsteroidal anti-inflammatory drug use and Alzheimer-type pathology in aging

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20681

7 January 2021

beta-Amyloid fibrils activate parallel mitogen-activated protein kinase pathways in microglia and THP1 monocytes.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20681

7 January 2021

Amyloid fibrils activate tyrosine kinase-dependent signaling and superoxide production in microglia.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20681

7 January 2021

The importance of inflammatory mechanisms in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20681

7 January 2021

Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20681

7 January 2021

Microglia in degenerative neurological disease.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20681

7 January 2021

Inflammation of the brain in Alzheimer's disease: implications for therapy.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20681

7 January 2021

Anti‐inflammatory agents as a therapeutic approach to Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20681

7 January 2021

Activation of microglial cells by beta-amyloid protein and interferon-gamma.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20681

7 January 2021

Neuroscience. The dark side of glia

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20681

7 January 2021

The neuropeptide PACAP attenuates beta-amyloid (1-42)-induced toxicity in PC12 cells

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20681

7 January 2021

P2X7 mediates superoxide production in primary microglia and is up-regulated in a transgenic mouse model of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20681

7 January 2021

Glia as a therapeutic target: selective suppression of human amyloid-beta-induced upregulation of brain proinflammatory cytokine production attenuates neurodegeneration.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20681

7 January 2021

Nonsteroidal anti-inflammatory drugs in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20681

7 January 2021

Clinical trial of indomethacin in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20681

7 January 2021

Differential Involvement of the Ras and Rap1 Small GTPases in Vasoactive Intestinal and Pituitary Adenylyl Cyclase Activating Polypeptides Control of the Prolactin Gene

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20681

7 January 2021

Risk of Alzheimer's disease and duration of NSAID use.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20681

7 January 2021

The role of inflammation in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20681

7 January 2021

Fibrillar beta-amyloid induces microglial phagocytosis, expression of inducible nitric oxide synthase, and loss of a select population of neurons in the rat CNS in vivo.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20681

7 January 2021

TGF-beta1 promotes microglial amyloid-beta clearance and reduces plaque burden in transgenic mice.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20681

7 January 2021

Peroxynitrite mediates neurotoxicity of amyloid beta-peptide1-42- and lipopolysaccharide-activated microglia.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20681

7 January 2021

VIP neurons in the human SCN in relation to sex, age, and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20681

7 January 2021

Identifiers

DOI

10.1002/GLIA.20681

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18442091%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18442091%20AND%20SRC:MED&resulttype=core&format=json